-
脓毒症是指因感染引起的宿主反应失调导致的危及生命的器官功能障碍,如果控制不及时,可能会发展为脓毒症性休克和多器官功能障碍综合征(MODS),病情进展急速且凶险[1]。脓毒症病人的死亡率文献报道不太一致,最高可达20%~80%,是造成急诊科和ICU病人死亡的常见疾病之一[2]。脓毒症性休克会造成病人多脏器的损伤,肾脏是其中最容易损伤的靶器官之一,因此,早期复苏成功和多器官功能支持对脓毒症病人的后续治疗及多脏器功能维护非常重要[3]。参附注射液是来源于中医古方“参附汤”,其具有扩张冠状血管、降低心肌耗氧量、减轻心肌缺血再灌注损伤以及抑制致炎因子的损伤等作用。尽管参附注射液已在临床广泛应用,但其是否有保护脓毒症病人的肾脏、肝脏及其他脏器功能的作用尚不明确。本文通过研究参附注射液对脓毒症病人急性肾损伤的治疗效果及对肝脏、心脏及脑钠肽的影响,为临床治疗脓毒症提供一定的依据。现作报道。
-
治疗前2组病人血清中Cr、BUN和Cys C水平差异均无统计学意义(P>0.05);治疗后,2组病人血清中Cr、BUN和Cys C水平均较治疗前均显著降低(P < 0.01),且观察组病人降低程度(改善)明显优于对照组(P < 0.01)(见表 1)。
分组 n Cr/(μmol/L) BUN/(mmol/L) Cys C/(mg/L) 治疗前 观察组 36 114.2±67.8 11.8±5.1 2.1±1.2 对照组 36 112.6±42.7 12.6±9.0 2.3±1.1 t — 0.12* 0.46* 0.74 P — > 0.05 > 0.05 > 0.05 治疗后 观察组 36 70.5±39.6△△ 5.6±0.9△△ 1.1±0.4△△ 对照组 36 91.0±43.4△△ 6.8±1.5△△ 1.4±0.4△△ t — 2.09 4.12* 3.18 P — < 0.05 < 0.01 < 0.01 *示t′值;组内配对t检验:△△P < 0.01 表 1 2组病人治疗前后Cr、BUN和Cys C的水平变化比较(x±s)
-
治疗前2组病人ALT、AST、LDH、CK和BNP的水平差异均无统计学意义(P>0.05);治疗后,2组病人血清中ALT、AST、LDH、CK和BNP的水平均较治疗前明显降低(P < 0.01);且观察组病人降低程度(改善)明显优于对照组(P < 0.01)(见表 2)。
分组 n ALT/(U/L) AST/(U/L) LDH/(U/L) CK/(U/L) BNP/(pg/mL) 治疗前 观察组 36 95.3±24.8 96.4±25.4 730.3±110.3 400.1±101.8 419.1±75.7 对照组 36 96.3±50.2 93.6±47.2 731.1±213.2 407.4±84.8 413.9±103.5 t — 0.11* 0.31* 0.02* 0.33 0.24 P — > 0.05 > 0.05 > 0.05 > 0.05 > 0.05 治疗后 观察组 36 51.4±12.2△△ 49.9±11.3△△ 514.2±86.9△△ 228.0±93.4△△ 134.9±84.6△△ 对照组 36 72.0±25.9△△ 70.9±45.9△△ 630.3±209.2△△ 323.4±37.7△△ 244.8±80.3△△ t — 4.32* 2.67 3.08* 5.68* 5.65 P — < 0.01 < 0.05 < 0.01 < 0.01 < 0.01 *示t′值;组内配对t检验:△△P < 0.01 表 2 2组病人治疗前后脏器损伤指标变化比较(x±s)
-
观察组病人治疗后死亡1人,存活35人,死亡率2.8%;对照组病人治疗后死亡8例,存活28例,死亡率22.2%;对照组病人的死亡率明显高于观察组(χ2=4.57, P < 0.05)。Kaplan-Meier生存分析提示观察组病人治疗后的生存时间明显长于对照组病人(log-rank=6.038,P < 0.05)(见图 1)。
参附注射液对脓毒症病人急性肾损伤的效果
Effect of Shenfu injection on acute renal injury induced by sepsis
-
摘要:
目的分析参附注射液对脓毒症病人急性肾损伤及其他脏器损伤的治疗效果。 方法将72例脓毒症病人随机分成对照组和观察组各36例,对照组病人按照指南给予标准治疗,观察组病人在标准治疗的基础上添加参附注射液。比较2组病人治疗前后血清肌酐、血尿素氮、胱抑素C水平的变化情况、其他脏器损伤以及死亡情况。 结果治疗前2组病人血清肌酐、血尿素氮、胱抑素C水平差异均无统计学意义(P>0.05),治疗后均比治疗前明显降低(P < 0.01),且观察组明显低于对照组(P < 0.01);治疗前2组病人丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、乳酸脱氢酶、肌酸激酶及脑钠肽水平差异均无统计学意义(P>0.05),治疗后水平均明显降低(P < 0.01),且观察组低于对照组(P < 0.01);观察组病人的死亡率(2.8%)明显低于对照组(22.2%)(P < 0.05),且生存时间也长于对照组(P < 0.05)。 结论参附注射液可有效减轻脓毒症病人急性肾损伤及其他脏器损伤,降低死亡率。 Abstract:ObjectiveTo investigate the therapeutic effects of Shenfu injection in the acute renal injury and other organs injury induced by sepsis. MethodsSeventy-two patients with sepsis were randomly divided into the control group and observation group (36 cases each group).The control group was treated with routine method, and the observation group was treated with Shenfu injection combined with conventional method.The changes of the serum levels of creatinine, blood urea nitrogen and cystatin C in two groups between before and after treatment, and other organ damage and death between two groups were compared. ResultsThe differences of the levels of serum creatinine, blood urea nitrogen and cystatin C between two groups before treatment were not statistically significant (P>0.05), which were significantly higher than those after treatment, and the levels of serum creatinine, blood urea nitrogen and cystatin C in observation group after treatment were significantly lower than those in control group (P < 0.01).The differences the levels of serum alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, creatine kinase and brain natriuretic peptide between two groups before treatment were not statistically significant (P>0.05), which in two groups significantly decreased after treatment, and the levels of serum alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, creatine kinase and brain natriuretic peptide in observation group were lower than those in control group (P < 0.01).The death rate in observation group (2.8%) was significantly lower than that in control group (22.2%) (P < 0.05), and the survival time in observation group was longer than that in control group (P < 0.05). ConclusionsShenfu injection can effectively alleviate the acute kidney injury and other organs injury, and reduce the mortality in sepsis patients. -
Key words:
- sepsis /
- acute renal injury /
- Shenfu injection /
- creatinine /
- urea nitrogen /
- cystatin C
-
表 1 2组病人治疗前后Cr、BUN和Cys C的水平变化比较(x±s)
分组 n Cr/(μmol/L) BUN/(mmol/L) Cys C/(mg/L) 治疗前 观察组 36 114.2±67.8 11.8±5.1 2.1±1.2 对照组 36 112.6±42.7 12.6±9.0 2.3±1.1 t — 0.12* 0.46* 0.74 P — > 0.05 > 0.05 > 0.05 治疗后 观察组 36 70.5±39.6△△ 5.6±0.9△△ 1.1±0.4△△ 对照组 36 91.0±43.4△△ 6.8±1.5△△ 1.4±0.4△△ t — 2.09 4.12* 3.18 P — < 0.05 < 0.01 < 0.01 *示t′值;组内配对t检验:△△P < 0.01 表 2 2组病人治疗前后脏器损伤指标变化比较(x±s)
分组 n ALT/(U/L) AST/(U/L) LDH/(U/L) CK/(U/L) BNP/(pg/mL) 治疗前 观察组 36 95.3±24.8 96.4±25.4 730.3±110.3 400.1±101.8 419.1±75.7 对照组 36 96.3±50.2 93.6±47.2 731.1±213.2 407.4±84.8 413.9±103.5 t — 0.11* 0.31* 0.02* 0.33 0.24 P — > 0.05 > 0.05 > 0.05 > 0.05 > 0.05 治疗后 观察组 36 51.4±12.2△△ 49.9±11.3△△ 514.2±86.9△△ 228.0±93.4△△ 134.9±84.6△△ 对照组 36 72.0±25.9△△ 70.9±45.9△△ 630.3±209.2△△ 323.4±37.7△△ 244.8±80.3△△ t — 4.32* 2.67 3.08* 5.68* 5.65 P — < 0.01 < 0.05 < 0.01 < 0.01 < 0.01 *示t′值;组内配对t检验:△△P < 0.01 -
[1] 张文喜, 段达荣, 张震宇, 等.参附注射液联合低分子肝素对小儿脓毒血症血浆NT-ProBNP、Cys、凝血功能和预后的影响[J].中国现代医学杂志, 2017, 27(2):61. doi: 10.3969/j.issn.1005-8982.2017.02.011 [2] 卢中秋, 卢才教, 洪广亮, 等.34例创伤弧菌脓毒症患者的流行病学特点及临床诊治[J].中华急诊医学杂志, 2009, 18(7):732. doi: 10.3760/cma.j.issn.1671-0282.2009.07.017 [3] 常瑜, 郝正玮, 郭霞, 等.参附注射液治疗脓毒血症的效果及影响因素的Logistic回归分析[J].实用药物与临床, 2015, 18(9):1055. [4] DELLINGER RP, LEVY MM, RHODES A, et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock, 2012[J].Intensive Care Med, 2013, 39(2):165. doi: 10.1007/s00134-012-2769-8 [5] 陈佳顺, 姚盛.参附注射液治疗难治性脓毒血症并休克的临床观察[J].中国实用医药, 2016, 11(19):161. [6] 张国刚.参附注射液治疗30例脓毒症患者的临床观察[J].中国中医急症, 2015, 24(7):1268. doi: 10.3969/j.issn.1004-745X.2015.07.056 [7] 陈勉, 胡志华, 陈伟, 等.持续血液净化疗法治疗外伤继发性脓毒症临床效果及对高迁移率族蛋白1、肿瘤坏死因子-α和促血管生成素2的影响[J].中国现代医学杂志, 2014, 24(34):61. doi: 10.3969/j.issn.1005-8982.2014.34.015 [8] 田虹, 王洪霞.老年脓毒症患者凝血功能紊乱及与预后的关系[J].中国急救医学, 2014, 34(11):966. doi: 10.3969/j.issn.1002-1949.2014.11.03 [9] MAKI DG, ROSENTHAL VD, SALOMAO R, et al.Impact of switching from an open a closed infusion system on rates of central line-associated bloodstream infection:a meta-analysis of time-sequence cohort studies in 4 countries[J].Infect Control Hosp Epidemiol, 2011, 32(1):50. doi: 10.1086/657632 [10] LAI TS, WANG CY, PAN SC, et al.Risk of developing severe sepsis after acute kidney injury:a population-based cohort study[J].Crit Care, 2013, 17(5):R231. doi: 10.1186/cc13054 [11] 中华医学会重症医学分会.中国严重脓毒症/脓毒性休克治疗指南(2014)[J].中华内科杂志, 2015, 54(6):557. [12] SAFAEI ASL A, DADASHZADEH P.Acute kidney injury in patients with paraquat intoxication; a case report and review of the literature[J].J Renal Inj Prev, 2016, 5(4):203. doi: 10.15171/jrip.2016.43 [13] 罗苑苑, 林新峰, 岳金芳, 等.从p38MAPK途径探讨参附注射液对脓毒症大鼠心功能的影响[J].广州中医药大学学报, 2017, 34(3):394. [14] HEMANDEZ G, BRUHN A, CASTRO R, et al.The holistic view on perfusion monitoring in septic shock[J].Curt Opin Crit Care, 2012, 18(3):280. doi: 10.1097/MCC.0b013e3283532c08